Table 3 of Inagaki, Mol Vis 2006; 12:673-680.


Table 3.

Allele and genotype frequency of ADRB1 and ADRB2 polymorphisms in Japanese glaucoma patients and controls. Data shown are counts with percentage in parentheses. Frequencies of genotypes and alleles were compared between patients and controls by χ2 analysis. The Bonferroni correction was used to adjust for multiple comparisons for static analysis of each SNP. The Arg389Gly polymorphism of the ADRB1 gene was significantly associated with NTG, showing a significantly different allele frequency in NTG patients and control subjects (p=0.004). Distribution of the Arg389Gly genotype also differed significantly between NTG patients and control subjects (p=0.006). P value from χ2 test. The asterisk indicates a p<0.0125, Bonferroni correction.

                                Allele frecuency (percentage)                             Genotype frequency (percentage)
                        ---------------------------------------------              ---------------------------------------------
Polymorphism   Allele      OAG        POAG         NTG       Control    Genotype      OAG        POAG         NTG       Control
------------   ------   ---------   ---------   ---------   ---------   --------   ---------   ---------   ---------   ---------
                        (n=1010)     (n=422)     (n=588)     (n=480)                (n=505)     (n=211)     (n=294)     (n=240)
ADRB1           Ser     872(86.3)   362(85.8)   510(86.7)   415(86.5)   Ser/Ser    374(74.1)   155(73.5)   219(74.5)   176(73.3)
Ser49Gly        Gly     138(13.7)    60(14.2)    78(13.3)    65(13.5)   Ser/Gly    124(24.6)    52(24.6)    72(24.5)    63(26.3)
                                                                        Gly/Gly      7( 1.4)     4( 1.9)     3( 1.0)     1( 0.4)
                         p=0.949     p=0.769     p=0.895                            p=0.405     p=0.313     p=0.666

                        (n=1002)     (n=420)     (n=582)     (n=474)                (n=501)     (n=210)     (n=291)     (n=237)
ADRB1           Arg     821(81.9)   332(79.0)   489(84.0)   365(77.0)   Arg/Arg    335(66.9)   132(62.9)   203(69.8)   143(60.3)
Arg389Gly       Gly     181(18.1)    88(21.0)    93(16.0)   109(23.0)   Arg/Gly    151(30.1)    68(32.4)    83(28.5)    79(33.3)
                                                                        Gly/Gly     15( 3.0)    10(4.8)      5( 1.7)    15( 6.3)
                         p=0.026     p=0.462     p=0.004*                           p=0.050     p=0.728     p=0.006*

                         (n=950)     (n=406)     (n=544)     (n=472)                (n=475)     (n=203)     (n=272)     (n=236)
ADRB2           Arg     470(49.5)   189(46.6)   281(51.7)   224(47.5)   Arg/Arg    100(21.1)    39(19.2)    61(22.4)    53(22.5)
Arg16Gly        Gly     480(50.5)   217(53.4)   263(48.3)   248(52.5)   Arg/Gly    270(56.8)   111(54.7)   159(58.5)   118(50.0)
                                                                        Gly/Gly    105(22.1)    53(26.1)    52(19.1)    65(27.5)
                         p=0.474     p=0.789     p=0.182                            p=0.178     p=0.580     p=0.062

                         (n=938)     (n=388)     (n=550)     (n=466)                (n=469)     (n=194)     (n=275)     (n=233)
ADRB2           Gln     881(93.9)   358(92.3)   523(95.1)   432(92.7)   Gln/Gln    415(88.5)   164(84.5)   251(91.3)   199(85.4)
Gln27Glu        Glu      57( 6.1)    30( 7.7)    27( 4.9)    34( 7.3)   Gln/Glu     51(10.9)    30(15.5)    21( 7.6)    34(14.6)
                                                                        Glu/Glu      3( 0.6)     0( 0.0)     3( 1.1)     0( 0.0)
                         p=0.382     p=0.810     p=0.111                            p=0.179     p=0.969     p=0.031

Inagaki, Mol Vis 2006; 12:673-680 <http://www.molvis.org/molvis/v12/a75/>
©2006 Molecular Vision <http://www.molvis.org/molvis/>
ISSN 1090-0535